BiMe

Transcriptomics in delineation of complex diseases as well as drug repurposing

Datum
17.12.2019
Zeit
11:00 - 12:00
Sprecher
Prof. Dr. Stefan Jovinge
Zugehörigkeit
Fredrik Meijer Heart and Vascular Institute, Spectrum Health
Serie
CMCB Life Sciences Seminar
Sprache
en
Hauptthema
Biologie
Andere Themen
Biologie, Medizin
Host
Dr. Olaf Bergmann
Beschreibung
Abstract: Patients with rare diseases such as monogenetic cardiomyopathies are in desperate need for drugs targeting their disease. The cost of drug development from initial concept to FDA approval has been estimated to be about 2.6 billion USD. With high throughput transcriptomics the Library of Integrated Network-based Cellular Signatures (LINCS) has publicly released transcriptional profiles quantifying the effects of more than 25,000 perturbagens on the expression of 978 genes in up to 77 cell lines. We have cross-referenced drugs across the whole database ending up with 1.3 billion data points. With this strategy we identified drugs to target the consequences of Lamin A/C haploinsufficiency causing dilated cardiomyopathy with severe arrhythmogenicity. These drugs which have already been approved for the use in humans and can be repurposed. This approach comes at a fraction of the cost of traditional drug development through transcriptional matching the disease to the drugs in the database and sequential testing of the candidate drugs against iPSC derived cardiomyocytes from healthy and diseased humans. Publications:1: Milliron HY, Weiland MJ, Kort EJ, Jovinge S. Isolation of CardiomyocytesUndergoing Mitosis with Complete Cytokinesis. Circ Res. 2019 Oct 25. 2: Li G, Tian L, Goodyer W, Kort EJ, Buikema JW, Xu A, Wu JC, Jovinge S, Wu SM.Single cell expression analysis reveals anatomical and cell cycle-dependenttranscriptional shifts during heart development. Development. 2019 Jun14;146(12). 3: Kort EJ, Jovinge S. Streamlined analysis of LINCS L1000 data with the slinkypackage for R. Bioinformatics. 2019 Sep 1;35(17):3176-3177. 4: Marinković G, Grauen Larsen H, Yndigegn T, Szabo IA, Mares RG, de Camp L,Weiland M, Tomas L, Goncalves I, Nilsson J, Jovinge S, Schiopu A. Inhibition ofpro-inflammatory myeloid cell responses by short-term S100A9 blockade improvescardiac function after myocardial infarction. Eur Heart J. 2019 Aug21;40(32):2713-2723.
Links

Letztmalig verändert: 06.12.2019, 00:05:31

Veranstaltungsort

Center for Regenerative Therapies Dresden (CRTD, ground floor, auditorium left)Fetscherstraße10501307Dresden
Telefon
+49 (0)351 458 82064
Fax
+49 (0)351 458 82059
E-Mail
TUD CRTD
Homepage
http://www.crt-dresden.de

Veranstalter

Center for Regenerative Therapies DresdenFetscherstraße 10501307Dresden
Telefon
+49 (0)351 458 82064
Fax
+49 (0)351 458 82059
E-Mail
TUD CRTD
Homepage
http://www.crt-dresden.de
Scannen Sie diesen Code mit Ihrem Smartphone and bekommen Sie die Veranstaltung direkt in Ihren Kalender. Sollten Sie Probleme beim Scannen haben, vergrößern Sie den Code durch Klicken darauf.
  • AuAusgründung/Transfer
  • BaBauing., Architektur
  • BiBiologie
  • ChChemie
  • ElElektro- u. Informationstechnik
  • GsGesellschaft, Philos., Erzieh.
  • InInformatik
  • JuJura
  • MwMaschinenwesen
  • MtMaterialien
  • MaMathematik
  • MeMedizin
  • PhPhysik
  • PsPsychologie
  • KuSprache, Literatur und Kultur
  • UmUmwelt
  • VeVerkehr
  • WeWeiterbildung
  • WlWillkommen
  • WiWirtschaft